🎉 M&A multiples are live!
Check it out!

Demant Valuation Multiples

Discover revenue and EBITDA valuation multiples for Demant and similar Medical Devices companies like Myomo, InfuSystem, and Electromed.

Demant Overview

About Demant

Demant AS is a Denmark-based company engaged in the healthcare industry. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments. The Company operates through more than 90 subsidiaries and associates all around the world. More than 80% of the company's sales come from North America and Europe.


Founded

1904

HQ

Denmark
Employees

22.6K+

Website

demant.com

Financials

LTM Revenue $3.2B

LTM EBITDA $828M

EV

$10.0B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Demant Financials

Demant has a last 12-month revenue of $3.2B and a last 12-month EBITDA of $828M.

In the most recent fiscal year, Demant achieved revenue of $3.1B and an EBITDA of $811M.

Demant expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Demant valuation multiples based on analyst estimates

Demant P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue $2.8B $3.1B $3.1B $3.2B XXX
Gross Profit $2.0B $2.3B $2.4B XXX XXX
Gross Margin 74% 74% 76% XXX XXX
EBITDA $600M $739M $811M $828M XXX
EBITDA Margin 22% 24% 26% 26% XXX
Net Profit $291M $251M $333M XXX XXX
Net Margin 11% 8% 11% XXX XXX
Net Debt $1.6B $1.5B $1.6B XXX XXX

Financial data powered by Morningstar, Inc.

Demant Stock Performance

As of February 21, 2025, Demant's stock price is DKK 266 (or $37).

Demant has current market cap of DKK 56.7B (or $7.9B), and EV of DKK 71.2B (or $10.0B).

See Demant trading valuation data

Demant Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$10.0B $7.9B XXX XXX XXX XXX $1.88

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Demant Valuation Multiples

As of February 21, 2025, Demant has market cap of $7.9B and EV of $10.0B.

Demant's trades at 3.1x LTM EV/Revenue multiple, and 12.0x LTM EBITDA.

Analysts estimate Demant's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Demant and 10K+ public comps

Demant Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $10.0B XXX XXX XXX
EV/Revenue 3.2x XXX XXX XXX
EV/EBITDA 12.3x XXX XXX XXX
P/E 23.7x XXX XXX XXX
P/E/Growth 1.2x XXX XXX XXX
EV/FCF 21.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Demant Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Demant Valuation Multiples

Demant's NTM/LTM revenue growth is 8%

Demant's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Demant's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Demant's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Demant and other 10K+ public comps

Demant Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 0% XXX XXX XXX XXX
EBITDA Margin 26% XXX XXX XXX XXX
EBITDA Growth 10% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 34% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 46% XXX XXX XXX XXX
G&A Expenses to Revenue 5% XXX XXX XXX XXX
R&D Expenses to Revenue 6% XXX XXX XXX XXX
Opex to Revenue 57% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Demant Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
Electromed XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Demant M&A and Investment Activity

Demant acquired  XXX companies to date.

Last acquisition by Demant was  XXXXXXXX, XXXXX XXXXX XXXXXX . Demant acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Demant

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Demant

When was Demant founded? Demant was founded in 1904.
Where is Demant headquartered? Demant is headquartered in Denmark.
How many employees does Demant have? As of today, Demant has 22.6K+ employees.
Who is the CEO of Demant? Demant's CEO is Mr. Soren Nielsen.
Is Demant publicy listed? Yes, Demant is a public company listed on CSE.
What is the stock symbol of Demant? Demant trades under DEMANT ticker.
When did Demant go public? Demant went public in 1995.
Who are competitors of Demant? Similar companies to Demant include e.g. Philips, Perspective Therapeutics, Electromed, InfuSystem.
What is the current market cap of Demant? Demant's current market cap is $7.9B
What is the current revenue of Demant? Demant's last 12-month revenue is $3.2B.
What is the current EBITDA of Demant? Demant's last 12-month EBITDA is $828M.
What is the current EV/Revenue multiple of Demant? Current revenue multiple of Demant is 3.1x.
What is the current EV/EBITDA multiple of Demant? Current EBITDA multiple of Demant is 12.0x.
What is the current revenue growth of Demant? Demant revenue growth between 2023 and 2024 was 0%.
Is Demant profitable? Yes, Demant is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.